Aberrant EGFR and Chromosome 7 Associate with Outcome in Laryngeal Cancer

Objectives/Hypothesis: Epidermal growth factor receptor (EGFR) over‐expression has been reported as a prognostic indicator in laryngeal cancer; however, the association with disease outcome has been inconsistent among studies. Here, we use fluorescence in situ hybridization (FISH) in addition to imm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Laryngoscope 2005-07, Vol.115 (7), p.1212-1218
Hauptverfasser: Morrison, Larry E., Jacobson, Kristine K., Friedman, Michael, Schroeder, James W., Coon, John S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1218
container_issue 7
container_start_page 1212
container_title The Laryngoscope
container_volume 115
creator Morrison, Larry E.
Jacobson, Kristine K.
Friedman, Michael
Schroeder, James W.
Coon, John S.
description Objectives/Hypothesis: Epidermal growth factor receptor (EGFR) over‐expression has been reported as a prognostic indicator in laryngeal cancer; however, the association with disease outcome has been inconsistent among studies. Here, we use fluorescence in situ hybridization (FISH) in addition to immunohistochemistry to assess laryngeal squamous cell carcinoma (SCC) to determine whether FISH can better predict patient outcome. Study Design: Retrospective study on 59 patients presenting with advanced disease. Methods: EGFR and chromosome 7 genomic statuses were measured using FISH, and EGFR expression was assessed by immunohistochemistry on formalin‐fixed, paraffin‐embedded specimens and correlated with outcome in the 59 patients. Results: EGFR expression was marginally associated with outcome, whereas both EGFR and chromosome 7 FISH status were significantly associated with outcome, and the combination of EGFR and chromosome 7 FISH status provided the strongest association of any two combined parameters (P = .0004). Combining EGFR expression with EGFR and chromosome 7 FISH status provided further improvement (P > .0001). Conclusions: Measurements of EGFR and chromosome 7 FISH status, and to a lesser extent EGFR expression, have potential value in treatment planning for patients with laryngeal SCC.
doi_str_mv 10.1097/01.MLG.0000163755.21035.8F
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67999036</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67999036</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4483-5c83e425a1d31d49e5bde43c46fbd55e24418b7736f05960b20894630c5167823</originalsourceid><addsrcrecordid>eNqVkM1u1DAURi0EokPhFZCFBLuE69jXjtmNRs20UmhRBaKsLMdxaCA_xc6o9O1xmRGzxpLlhc_3-foQ8oZBzkCr98Dyj_U2h7SY5AoxLxhwzMvqCVkx5CwTWuNTsgIoeFZicXNCXsT4I-GKIzwnJwwTgKBX5GLd-BDstNCzbXVN7dTSzW2YxznOo6eKrmOcXW8XT-_75ZZe7Rb3eNFPtLbhYfru7UA3dnI-vCTPOjtE_-pwnpIv1dnnzXlWX20vNus6c0KUPENXci8KtKzlrBXaY9N6wZ2QXdMi-kIIVjZKcdkBaglNAaUWkoNDJlVZ8FPybt97F-ZfOx8XM_bR-WGwk5930UiltQYuE_hhD7owxxh8Z-5CP6apDQPzKNIAM0mkOYo0f0Waskrh14dXds3o22P0YC4Bbw-Ajc4OXXLo-njkpBaYduKqPXffD_7hP0Yw9fr6G6JgDEExnoqyfVEfF__7X5ENP9OXU9J8vdwaeSmKT9XNuan4HxvXnEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67999036</pqid></control><display><type>article</type><title>Aberrant EGFR and Chromosome 7 Associate with Outcome in Laryngeal Cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Morrison, Larry E. ; Jacobson, Kristine K. ; Friedman, Michael ; Schroeder, James W. ; Coon, John S.</creator><creatorcontrib>Morrison, Larry E. ; Jacobson, Kristine K. ; Friedman, Michael ; Schroeder, James W. ; Coon, John S.</creatorcontrib><description>Objectives/Hypothesis: Epidermal growth factor receptor (EGFR) over‐expression has been reported as a prognostic indicator in laryngeal cancer; however, the association with disease outcome has been inconsistent among studies. Here, we use fluorescence in situ hybridization (FISH) in addition to immunohistochemistry to assess laryngeal squamous cell carcinoma (SCC) to determine whether FISH can better predict patient outcome. Study Design: Retrospective study on 59 patients presenting with advanced disease. Methods: EGFR and chromosome 7 genomic statuses were measured using FISH, and EGFR expression was assessed by immunohistochemistry on formalin‐fixed, paraffin‐embedded specimens and correlated with outcome in the 59 patients. Results: EGFR expression was marginally associated with outcome, whereas both EGFR and chromosome 7 FISH status were significantly associated with outcome, and the combination of EGFR and chromosome 7 FISH status provided the strongest association of any two combined parameters (P = .0004). Combining EGFR expression with EGFR and chromosome 7 FISH status provided further improvement (P &gt; .0001). Conclusions: Measurements of EGFR and chromosome 7 FISH status, and to a lesser extent EGFR expression, have potential value in treatment planning for patients with laryngeal SCC.</description><identifier>ISSN: 0023-852X</identifier><identifier>EISSN: 1531-4995</identifier><identifier>DOI: 10.1097/01.MLG.0000163755.21035.8F</identifier><identifier>PMID: 15995509</identifier><identifier>CODEN: LARYA8</identifier><language>eng</language><publisher>Hoboken, NJ: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Chromosome Aberrations ; Chromosomes, Human, Pair 7 - genetics ; Female ; Genes, erbB-1 - genetics ; Humans ; In Situ Hybridization, Fluorescence ; Laryngeal Neoplasms - genetics ; Laryngeal Neoplasms - mortality ; Laryngeal Neoplasms - pathology ; Male ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Otorhinolaryngology. Stomatology ; Prognosis ; Retrospective Studies ; Survival Rate ; Tumors ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><ispartof>The Laryngoscope, 2005-07, Vol.115 (7), p.1212-1218</ispartof><rights>Copyright © 2005 The Triological Society</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4483-5c83e425a1d31d49e5bde43c46fbd55e24418b7736f05960b20894630c5167823</citedby><cites>FETCH-LOGICAL-c4483-5c83e425a1d31d49e5bde43c46fbd55e24418b7736f05960b20894630c5167823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1097%2F01.MLG.0000163755.21035.8F$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1097%2F01.MLG.0000163755.21035.8F$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16945694$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15995509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morrison, Larry E.</creatorcontrib><creatorcontrib>Jacobson, Kristine K.</creatorcontrib><creatorcontrib>Friedman, Michael</creatorcontrib><creatorcontrib>Schroeder, James W.</creatorcontrib><creatorcontrib>Coon, John S.</creatorcontrib><title>Aberrant EGFR and Chromosome 7 Associate with Outcome in Laryngeal Cancer</title><title>The Laryngoscope</title><addtitle>The Laryngoscope</addtitle><description>Objectives/Hypothesis: Epidermal growth factor receptor (EGFR) over‐expression has been reported as a prognostic indicator in laryngeal cancer; however, the association with disease outcome has been inconsistent among studies. Here, we use fluorescence in situ hybridization (FISH) in addition to immunohistochemistry to assess laryngeal squamous cell carcinoma (SCC) to determine whether FISH can better predict patient outcome. Study Design: Retrospective study on 59 patients presenting with advanced disease. Methods: EGFR and chromosome 7 genomic statuses were measured using FISH, and EGFR expression was assessed by immunohistochemistry on formalin‐fixed, paraffin‐embedded specimens and correlated with outcome in the 59 patients. Results: EGFR expression was marginally associated with outcome, whereas both EGFR and chromosome 7 FISH status were significantly associated with outcome, and the combination of EGFR and chromosome 7 FISH status provided the strongest association of any two combined parameters (P = .0004). Combining EGFR expression with EGFR and chromosome 7 FISH status provided further improvement (P &gt; .0001). Conclusions: Measurements of EGFR and chromosome 7 FISH status, and to a lesser extent EGFR expression, have potential value in treatment planning for patients with laryngeal SCC.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Chromosome Aberrations</subject><subject>Chromosomes, Human, Pair 7 - genetics</subject><subject>Female</subject><subject>Genes, erbB-1 - genetics</subject><subject>Humans</subject><subject>In Situ Hybridization, Fluorescence</subject><subject>Laryngeal Neoplasms - genetics</subject><subject>Laryngeal Neoplasms - mortality</subject><subject>Laryngeal Neoplasms - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>Tumors</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><issn>0023-852X</issn><issn>1531-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkM1u1DAURi0EokPhFZCFBLuE69jXjtmNRs20UmhRBaKsLMdxaCA_xc6o9O1xmRGzxpLlhc_3-foQ8oZBzkCr98Dyj_U2h7SY5AoxLxhwzMvqCVkx5CwTWuNTsgIoeFZicXNCXsT4I-GKIzwnJwwTgKBX5GLd-BDstNCzbXVN7dTSzW2YxznOo6eKrmOcXW8XT-_75ZZe7Rb3eNFPtLbhYfru7UA3dnI-vCTPOjtE_-pwnpIv1dnnzXlWX20vNus6c0KUPENXci8KtKzlrBXaY9N6wZ2QXdMi-kIIVjZKcdkBaglNAaUWkoNDJlVZ8FPybt97F-ZfOx8XM_bR-WGwk5930UiltQYuE_hhD7owxxh8Z-5CP6apDQPzKNIAM0mkOYo0f0Waskrh14dXds3o22P0YC4Bbw-Ajc4OXXLo-njkpBaYduKqPXffD_7hP0Yw9fr6G6JgDEExnoqyfVEfF__7X5ENP9OXU9J8vdwaeSmKT9XNuan4HxvXnEg</recordid><startdate>200507</startdate><enddate>200507</enddate><creator>Morrison, Larry E.</creator><creator>Jacobson, Kristine K.</creator><creator>Friedman, Michael</creator><creator>Schroeder, James W.</creator><creator>Coon, John S.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>200507</creationdate><title>Aberrant EGFR and Chromosome 7 Associate with Outcome in Laryngeal Cancer</title><author>Morrison, Larry E. ; Jacobson, Kristine K. ; Friedman, Michael ; Schroeder, James W. ; Coon, John S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4483-5c83e425a1d31d49e5bde43c46fbd55e24418b7736f05960b20894630c5167823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Chromosome Aberrations</topic><topic>Chromosomes, Human, Pair 7 - genetics</topic><topic>Female</topic><topic>Genes, erbB-1 - genetics</topic><topic>Humans</topic><topic>In Situ Hybridization, Fluorescence</topic><topic>Laryngeal Neoplasms - genetics</topic><topic>Laryngeal Neoplasms - mortality</topic><topic>Laryngeal Neoplasms - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>Tumors</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morrison, Larry E.</creatorcontrib><creatorcontrib>Jacobson, Kristine K.</creatorcontrib><creatorcontrib>Friedman, Michael</creatorcontrib><creatorcontrib>Schroeder, James W.</creatorcontrib><creatorcontrib>Coon, John S.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>The Laryngoscope</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morrison, Larry E.</au><au>Jacobson, Kristine K.</au><au>Friedman, Michael</au><au>Schroeder, James W.</au><au>Coon, John S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aberrant EGFR and Chromosome 7 Associate with Outcome in Laryngeal Cancer</atitle><jtitle>The Laryngoscope</jtitle><addtitle>The Laryngoscope</addtitle><date>2005-07</date><risdate>2005</risdate><volume>115</volume><issue>7</issue><spage>1212</spage><epage>1218</epage><pages>1212-1218</pages><issn>0023-852X</issn><eissn>1531-4995</eissn><coden>LARYA8</coden><abstract>Objectives/Hypothesis: Epidermal growth factor receptor (EGFR) over‐expression has been reported as a prognostic indicator in laryngeal cancer; however, the association with disease outcome has been inconsistent among studies. Here, we use fluorescence in situ hybridization (FISH) in addition to immunohistochemistry to assess laryngeal squamous cell carcinoma (SCC) to determine whether FISH can better predict patient outcome. Study Design: Retrospective study on 59 patients presenting with advanced disease. Methods: EGFR and chromosome 7 genomic statuses were measured using FISH, and EGFR expression was assessed by immunohistochemistry on formalin‐fixed, paraffin‐embedded specimens and correlated with outcome in the 59 patients. Results: EGFR expression was marginally associated with outcome, whereas both EGFR and chromosome 7 FISH status were significantly associated with outcome, and the combination of EGFR and chromosome 7 FISH status provided the strongest association of any two combined parameters (P = .0004). Combining EGFR expression with EGFR and chromosome 7 FISH status provided further improvement (P &gt; .0001). Conclusions: Measurements of EGFR and chromosome 7 FISH status, and to a lesser extent EGFR expression, have potential value in treatment planning for patients with laryngeal SCC.</abstract><cop>Hoboken, NJ</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>15995509</pmid><doi>10.1097/01.MLG.0000163755.21035.8F</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0023-852X
ispartof The Laryngoscope, 2005-07, Vol.115 (7), p.1212-1218
issn 0023-852X
1531-4995
language eng
recordid cdi_proquest_miscellaneous_67999036
source MEDLINE; Wiley Online Library Journals
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Chromosome Aberrations
Chromosomes, Human, Pair 7 - genetics
Female
Genes, erbB-1 - genetics
Humans
In Situ Hybridization, Fluorescence
Laryngeal Neoplasms - genetics
Laryngeal Neoplasms - mortality
Laryngeal Neoplasms - pathology
Male
Medical sciences
Middle Aged
Neoplasm Staging
Otorhinolaryngology. Stomatology
Prognosis
Retrospective Studies
Survival Rate
Tumors
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
title Aberrant EGFR and Chromosome 7 Associate with Outcome in Laryngeal Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T11%3A55%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aberrant%20EGFR%20and%20Chromosome%207%20Associate%20with%20Outcome%20in%20Laryngeal%20Cancer&rft.jtitle=The%20Laryngoscope&rft.au=Morrison,%20Larry%20E.&rft.date=2005-07&rft.volume=115&rft.issue=7&rft.spage=1212&rft.epage=1218&rft.pages=1212-1218&rft.issn=0023-852X&rft.eissn=1531-4995&rft.coden=LARYA8&rft_id=info:doi/10.1097/01.MLG.0000163755.21035.8F&rft_dat=%3Cproquest_cross%3E67999036%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67999036&rft_id=info:pmid/15995509&rfr_iscdi=true